These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9951046

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ambivalent effect of long lasting terguride treatment on genetically based glycide and lipid metabolism abnormalities in SHR/N-cp Koletsky rats.
    Golda V.
    Acta Medica (Hradec Kralove); 1998; 41(2):81-5. PubMed ID: 9729641
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Terguride but not bromocriptine alleviated glucose tolerance abnormalities and hyperlipidaemia in obese and lean genetically hypertensive Koletsky rats.
    Golda V, Cvak L.
    Physiol Res; 1994; 43(5):299-305. PubMed ID: 7711008
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Terguride attenuates prolactin levels and ameliorates insulin sensitivity and insulin binding in obese spontaneously hypertensive rats.
    Golda V, Ficková M, Pinterova L, Jurcovicová J, Macho L, Zórad S.
    Physiol Res; 2001; 50(2):175-82. PubMed ID: 11522045
    [Abstract] [Full Text] [Related]

  • 7. Muscle GLUT-4 and insulin binding to erythrocytes and to adipose, liver and muscle tissue in genetically hypertensive obese rats and in their lean siblings: effect of long lasting terguride treatment.
    Golda V, Hilgertová J, Zórad S.
    Acta Medica (Hradec Kralove); 1998; 41(3):125-30. PubMed ID: 9919714
    [Abstract] [Full Text] [Related]

  • 8. Effect of terguride on insulin binding, insulinaemia, glucose tolerance and hyperlipaemia in lean SHR Koletsky rats.
    Golda V, Hilgertová J.
    Physiol Res; 1997; 46(6):439-42. PubMed ID: 9730050
    [Abstract] [Full Text] [Related]

  • 9. Development of lipid and glycide abnormalities in genetically hypertensive obese Koletsky rats and in their lean siblings.
    Golda V, Hilgertová J.
    Acta Medica (Hradec Kralove); 1998; 41(4):163-6. PubMed ID: 9951047
    [Abstract] [Full Text] [Related]

  • 10. Effects of terguride treatment on glucose abnormalities induced by ischemic brain damage in SHR/N-cp lean Koletsky strain and in rats of Wistar strain.
    Kudlackova Z, Golda V.
    Bratisl Lek Listy; 2004; 105(10-11):353-8. PubMed ID: 15658573
    [Abstract] [Full Text] [Related]

  • 11. Glucose intolerance induced by oligemic brain hypoxia: the effect of terguride.
    Golda V, Hilgertová J.
    Acta Medica (Hradec Kralove); 1997; 40(3):57-60. PubMed ID: 9465428
    [Abstract] [Full Text] [Related]

  • 12. Terguride treatment attenuated prolactin release and enhanced insulin receptor affinity and GLUT 4 content in obese spontaneously hypertensive female, but not male rats.
    Zorad S, Golda V, Fickova M, Macho L, Pinterova L, Jurcovicova J.
    Ann N Y Acad Sci; 2002 Jun; 967():490-9. PubMed ID: 12079879
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat.
    Pulvirenti L, Balducci C, Piercy M, Koob GF.
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1231-8. PubMed ID: 9732383
    [Abstract] [Full Text] [Related]

  • 16. Effect of diazepam in circadian rhythm of activity and in novelty induced hyperactivity in the genetically hypertensive rats of Koletsky type and in the normotensive rats of Wistar strain.
    Golda V.
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1991 Sep; 34(3):255-64. PubMed ID: 1788523
    [Abstract] [Full Text] [Related]

  • 17. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
    Lyoussi B, Ragala MA, Mguil M, Chraibi A, Israili ZH.
    Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
    [Abstract] [Full Text] [Related]

  • 18. [Terguride in hyperprolactinemia--experiences with 5 patients].
    Wüster C, Scholz A, Schmelzle A, Horowski R, Ziegler R.
    Klin Wochenschr; 1990 Apr 02; 68(7):384-7. PubMed ID: 2188044
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study.
    Hashimoto K, Sugawara N, Ishioka M, Nakamura K, Yasui-Furukori N.
    Neuropsychiatr Dis Treat; 2014 Apr 02; 10():1571-6. PubMed ID: 25187719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.